Tirzepatide is a breakthrough medication that belongs to a class of drugs known as dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists. In simpler terms, Tirzepatide works by mim-icking the action of the naturally occurring hormones GIP and GLP-1, which play crucial roles in regulating blood sugar levels and promoting satiety.